Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial
Ellis, Matthew J., Coop, Andrew, Singh, Baljit, Mauriac, Louis, Llombert-Cussac, Antonio, Jänicke, Fritz, Miller, William R., Evans, Dean B., Dugan, Margaret, Brady, Carolyn, Quebe-Fehling, Erhard, BoVolume:
19
Langue:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2001.19.18.3808
Date:
September, 2001
Fichier:
PDF, 177 KB
english, 2001